Drug firm Aurobindo Pharma today said its Chief Executive Officer (Formulations) Arvind Vasudeva has resigned from the company.

Aurobindo Pharma intends to invest up to Rs 900 cr this fiscal on various activities including capacity expansion, clinical trials and prod...

With effect from August 8, the Latin American nation has included India on the list of countries that can supply medicines to it.

Aurobindo Pharma Chief Executive Officer said the new licence would help ensure the timely introduction of generic ATV in developing countr...

The academic and corporate honcho bring along intense strategies and analyses. The activist and ex-cop arrive armed with steely resolve. An...

Glenmark Pharmaceuticals COO Arvind Vasudeva said the association would enable the firm to consolidate its leadership position in dermatolo...

RPG Life Sciences aims to more than double its turnover to Rs 400-crore by FY 12 and has rejigged its business strategy towards the formula...

Despite the leap-frogging growth projections for the healthcare-linked business, lack of awareness, infrastructure bottleneck and crunch in...

Clinical research outsourcing (CRO), touted as the next big think on the outsourcing sphere, is yet to take off.